To determine the effect of exercise on glycosylated haemoglobin (HbA1c) and body mass in people with type 2 diabetes.
Validity was assessed using the 5-point Jadad scale, which considers randomisation, blinding and withdrawals. In addition, the adequacy of concealment allocation was assessed. Two authors independently assessed validity and resolved any disagreements through discussion with a third author.
Data extraction
Two authors independently extracted the data. The tabulated information included the study location, characteristics of the participants, the number of participants per treatment group, concomitant medication and/or diet, study design and details of the interventions. Baseline and postintervention means and standard deviations were extracted or estimated from the graphs for each treatment group. The authors of the studies were contacted for missing data. The effect size was calculated for each study; standardised mean differences were used when the same outcome was assessed on different scales.
Methods of synthesis
How were the studies combined? The studies were grouped by treatment comparisons (exercise versus no exercise, and exercise plus diet versus no exercise plus no diet) and analysed separately. A pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were calculated with weighting by the inverse of the variance for HbA1c and body mass. A fixed-effect model was used. Publication bias was assessed using a funnel plot.
How were differences between studies investigated?
Statistical heterogeneity was assessed using the chi-squared statistic. Where significant heterogeneity was found, the data were to be reanalysed using a random-effects model. Sensitivity analyses were conducted by analysing randomised and non-randomised trials separately, by comparing results for aerobic and resistance training, and after excluding one study that only recruited patients older than 65 years. The relationship between differences in HbA1c and weight loss, exercise intensity, and exercise volume was explored using meta-regression.
Results of the review
Fourteen controlled clinical trials (CCTs) were included (504 patients), of which 11 were RCTs (412 patients) and 3 were non-RCTs (92 patients).
Study quality.
The studies were of moderate to low quality (mean Jadad score: 1.6).
HbA1c.
Exercise versus no exercise: 9 CCTs (8 RCTs and 1 non-RCT; 11 comparisons; 310 patients) were included. Exercise significantly lowered HbA1c compared with no exercise. HbAlc was 7.65% in the exercise group and 8.31% in the control group; the WMD was -0.66% (95% CI: -0.98, -0.34, P<0.001). No significant heterogeneity was detected (P=0.46).
Exercise plus diet versus no exercise plus no diet: 2 RCTs (3 comparisons; 142 patients) were included. Exercise plus diet significantly lowered HbA1c compared with no exercise plus no diet; the WMD was -0.76% (95% CI: -1.32,-0.20, P=0.008). No significant heterogeneity was detected (P=0.69).
The sensitivity analysis found similar results for randomised compared with non-randomised studies and for aerobic exercise compared with resistance training. The results were similar after excluding one study that enrolled only older patients.
Body mass.
Exercise and no exercise: 11 CCTs (8 RCTs and 3 non-RCTs; 13 comparisons; 368 patients) were included. There was no significant difference in body mass between exercise and no exercise; the WMD was 0.06% (95% CI: -0.15, +0.26,
